carubicin - CISMeF

Preferred Label : carubicin;

MeSH definition : A very toxic anthracycline-type antineoplastic related to DAUNORUBICIN, obtained from Actinomadura carminata.;

MeSH synonym : karminomicin; demethyldaunomycin; carminomicin; demethyldaunorubicin; karminomycin; Carminomycin; carminomycin i;

CISMeF synonym : 52794-97-5 (Carubicin hydrochloride);

MeSH hyponym : carminomycin III; rubeomycin A; NSC-180,024; carminomycin II; rubeomycin A1; carubicin hydrochloride; Hydrochloride, Carubicin; NSC 180,024; NSC180,024; NSC-180024; NSC 180024; NSC180024;

MeSH CAS label : carminomycin;

MeSH Related Number : carubicin hydrochloride; 39472-31-6 (Carubicin); 52794-97-5 (HCl); 4V3R166MB3;

Registry Number MeSH : 39472-31-6;

Related CAS MeSH : 4V3R166MB3 (Carubicin hydrochloride);

Wikipedia link : https://en.wikipedia.org/wiki/Carubicin;

Is substance : O;

UNII : E7437K3983;

InChIKey : XREUEWVEMYWFFA-CSKJXFQVSA-N;

Details

Origin ID

D002360;

UMLS CUI

C0007308;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Carubicin Hydrochloride [NCIt concept]
Currated CISMeF NLP mapping
- Carubicin [NCIt concept]
Pharmacological action(s)
- antibiotics, antineoplastic [MeSH Descriptor]
- enzyme inhibitors [MeSH Descriptor]
- topoisomerase II inhibitors [MeSH Descriptor]
Record concept(s)
- NSC-180,024 [MeSH concept]
- carminomycin II [MeSH concept]
- carminomycin III [MeSH concept]
- carubicin [MeSH concept]
- carubicin hydrochloride [MeSH concept]
- rubeomycin A [MeSH concept]
- rubeomycin A1 [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-hydroxy-11-deoxycarminomycin II [MeSH Supplementary Concept]
- 1-hydroxy-13-deoxocarminomycin [MeSH Supplementary Concept]
- 10-carboxy-13-deoxocarminomycin [MeSH Supplementary Concept]
- 13-deoxy-10-hydroxycarminomycin [MeSH Supplementary Concept]
- 13-deoxycarminomycin [MeSH Supplementary Concept]
- 13-dihydrocarminomycinone [MeSH Supplementary Concept]
- 14-N-succinimidocarminomycin [MeSH Supplementary Concept]
- 14-carminomycyl-N-pyridinium [MeSH Supplementary Concept]
- 14-chlorocarubicin [MeSH Supplementary Concept]
- 14-hydroxycarminomycin [MeSH Supplementary Concept]
- 14-oxycarminomycin [MeSH Supplementary Concept]
- 14-salicyloylcarubicin [MeSH Supplementary Concept]
- CCP protocol [MeSH Supplementary Concept]
- CD protocol [MeSH Supplementary Concept]
- N-formyl-13-dihydrocarminomycin [MeSH Supplementary Concept]
- SN 706 [MeSH Supplementary Concept]
- carminazine [MeSH Supplementary Concept]
- carminazone [MeSH Supplementary Concept]
- carminomycin 11-methyl ether [MeSH Supplementary Concept]
- carminomycin 13-cyclohexylidenehydrazone [MeSH Supplementary Concept]
- carminomycin-iron complex [MeSH Supplementary Concept]
- carminomycinone [MeSH Supplementary Concept]
- dihydrocarminomycin [MeSH Supplementary Concept]
- morpholinoanthracycline MX2 [MeSH Supplementary Concept]
- trisarubicinol [MeSH Supplementary Concept]
Semantic type(s)
- Antibiotic [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Carubicin [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients